Nrf2 Activating Compounds for Autoimmune Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for autoimmune and inflammatory diseases such as psoriasis and multiple sclerosis lack effective activation of Nrf2, a transcription factor that regulates antioxidant proteins, leading to inadequate protection against oxidative damage and inflammation.
Innovation Solution
Development of compounds that activate Nrf2, represented by specific chemical formulas (I) and (II), which can be used in pharmaceutical compositions to treat autoimmune and inflammatory diseases by increasing Nrf2 activity and providing protection against oxidative damage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments for autoimmune and inflammatory diseases are used, then disease management is maintained, but Nrf2 activation is insufficient leading to inadequate protection against oxidative damage
Solution Approach 1:
The patent develops novel chemical compounds with specific molecular structures (formula I and II) that fundamentally change the pharmacological parameters of Nrf2 activation. These compounds possess unique structural features including specific substituent groups and stereochemical configurations that enable potent and selective Nrf2 activation, directly addressing the insufficient Nrf2 activation capability of conventional treatments while providing reliable protection against oxidative damage
2Reliability
If Nrf2 activation is enhanced to improve antioxidant defenses, then protection against oxidative damage increases, but treatment complexity may increase
Solution Approach 1:
The patent segments the complex task of Nrf2 activation into specific molecular structural elements. The compounds are designed with defined structural components (amino acid derivatives, specific substituent patterns, stereochemical configurations) that can be systematically optimized. This segmentation allows for rational drug design where each structural element contributes to specific aspects of Nrf2 activation and antioxidant efficacy, making the treatment approach more manageable and developable despite the complexity of enhancing antioxidant defenses
Data Source
AI summary
Aspects of the present disclosure include compounds that activate Nrf2. Such compounds may find use in the treatment of autoimmune and inflammatory diseases and disorders, such as for example psoriasis and multiple sclerosis. Embodiments of the present disclosure also relate to pharmaceutical compositions that include these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.